A Short Information Manual on: The Tanzania National Drug Policy, The Master Plan for the Pharmaceutical Sector 1992-2000 Tanzania Mainland - A Summary, Hospital Therapeutic Committees: A. The Tanzania National Drug Policy: 3. Tanzania National Drug Policy 1991: II. Drug Availability: 4. Quality assurance

Home page | Help | Clear

English | French

Full TOC

Expand Document

Expand Chapter

Preferences

Printable HTML version

Export document as HTML file Help


A Short Information Manual on: The Tanzania National Drug Policy, The Master Plan for the Pharmaceutical Sector 1992-2000 Tanzania Mainland - A Summary, Hospital Therapeutic Committees (WHO; 1993; 42 pages)
	Foreword
	A. The Tanzania National Drug Policy
		1. Background
		2. Initial Activities
		3. Tanzania National Drug Policy 1991
			I. Introduction*
			II. Drug Availability
				1. Drug selection
				2. Drug procurement
				3. Distribution
				4. Quality assurance
			III. Rational Drug Use
				1. Education and Training
				2. Drug Information
				3. Control of Misuse
				4. Hospital Pharmaceuticals and Supplies Committees
				5. Advertising and Promotion
			IV. National Pharmaceutical Production
				1. Promotion
				2. Product Range and Coordination
				3. Pricing mechanisms
			V. Traditional Medicine
				1. Promotion
				2. Research and Production
				3. Safety and Use
			VI. Intersectoral Cooperation
			VII. Technical Cooperation with Other Countries
			VIII. Financial Resources
			IX. Legislation
		4. Notes of clarification on some statements in the National Drug Policy document
	B. The Masterplan for the Pharmaceutical Sector of Tanzania Mainland 1992 - 2000
		1. Introduction
		2. Central Medical Stores (CMS)
		3. Pharmaceuticals and Supplies Unit (PSU)
		4. Pharmacy Board
			4.1. General
			4.2. Drug Legislation
			4.3. Drug Registration
			4.4. Drug Inspection
			4.5. Drug Information
			4.6. Drug Advertising and Promotion
		5. Drug Quality Assurance and Control
		6. Local Production of Pharmaceutical Products
		7. Traditional Medicine
		8. Local Financing of Drugs
		9. Conclusions
	C. Hospital Therapeutic Committees
		I. Introduction
		II. Establishing Therapeutic Committees
		III. Functions of Hospital Therapeutic Committees
		IV. Discussion of the Functions
		V. Composition of Hospital Therapeutic Committees
		VI. Support of Hospital Therapeutic Committees

4. Quality assurance

a. The aim of the National Drug Policy is to ensure that drugs, reaching the patient are safe, effective and of high quality. The quality assurance system will include managerial, technical and legal elements (see notes 5,6 and 7).

b. The drug inspection system will assure that the policy is achieved in all aspects and at all levels of the drug supply system.
The relevant aspects of testing samples will be carried out in national drug control laboratories under the authority of the Government Chemist (see also note 6).

c. All specifications on pharmaceutical products will be stated in laws and regulations (see note 7).

Please provide your feedback

English | French